Stock Analysis

The Chairman of Alteco Medical AB (NGM:ALTE), Anders Althin, Just Bought 50% More Shares

NGM:ALTE
Source: Shutterstock

Those following along with Alteco Medical AB (NGM:ALTE) will no doubt be intrigued by the recent purchase of shares by Anders Althin, Chairman of the company, who spent a stonking kr7.0m on stock at an average price of kr0.98. That increased their holding by a full 50%, which arguably implies the sort of confidence required for a shy sweet-natured nerd to ask the most popular kid in the school to go out on a date.

See our latest analysis for Alteco Medical

The Last 12 Months Of Insider Transactions At Alteco Medical

In fact, the recent purchase by Anders Althin was the biggest purchase of Alteco Medical shares made by an insider individual in the last twelve months, according to our records. That means that an insider was happy to buy shares at around the current price of kr0.99. That means they have been optimistic about the company in the past, though they may have changed their mind. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today's share price, as the discount to value may have narrowed with the rising price. The good news for Alteco Medical share holders is that an insider was buying at near the current price. Anders Althin was the only individual insider to buy shares in the last twelve months.

You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

insider-trading-volume
NGM:ALTE Insider Trading Volume January 12th 2021

Alteco Medical is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Insider Ownership of Alteco Medical

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. It's great to see that Alteco Medical insiders own 43% of the company, worth about kr21m. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

What Might The Insider Transactions At Alteco Medical Tell Us?

It is good to see the recent insider purchase. We also take confidence from the longer term picture of insider transactions. But we don't feel the same about the fact the company is making losses. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about Alteco Medical. That's what I like to see! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Alteco Medical. To that end, you should learn about the 5 warning signs we've spotted with Alteco Medical (including 4 which are a bit unpleasant).

Of course Alteco Medical may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

If you decide to trade Alteco Medical, use the lowest-cost* platform that is rated #1 Overall by Barron’s, Interactive Brokers. Trade stocks, options, futures, forex, bonds and funds on 135 markets, all from a single integrated account. Promoted


New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.